Skip to main content

Healthy Skin

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Galderma
GaldermaTX - Dallas
1 program
1
adapalen 0.1%Phase 41 trial
Active Trials
NCT00971282Completed30Est. May 2009
Apollo Therapeutics
Apollo TherapeuticsUK - Cambridge
1 program
ApolloVue® S100 Image SystemN/A1 trial
Active Trials
NCT04406454Completed60Est. Feb 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Galdermaadapalen 0.1%
Apollo TherapeuticsApolloVue® S100 Image System

Clinical Trials (2)

Total enrollment: 90 patients across 2 trials

NCT00971282Galdermaadapalen 0.1%

Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-Up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins

Start: Dec 2008Est. completion: May 200930 patients
Phase 4Completed
NCT04406454Apollo TherapeuticsApolloVue® S100 Image System

The Application of Non-invasive and Cellular Level Resolution Fullfield Optical Coherence Tomography: Establishment and Analysis of Subcutaneous Cellular Level Image Database of Anatomical Locations in Healthy Volunteers and Evaluation of Usability

Start: Jul 2020Est. completion: Feb 202260 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.